St. Jude Medical Announces Intent to Acquire Spinal Modulation, Inc. (MarketWatch)
All stories about Spinal Modulation
Mergers and Acquisitions in Orthopedics
St. Jude Medical to add DRG stimulation technology to its chronic pain portfolio, expanding the company’s range of treatment options for the management of chronic pain
ST. PAUL, Minn., Apr 20, 2015 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, +0.83% a global medical device company, today announced it has exercised the company’s exclusive option to acquire Spinal Modulation, Inc., developer of the Axium™ Neurostimulator System. Following the completion of this acquisition, St. Jude Medical will become the only medical device manufacturer to offer radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.
Once complete, the acquisition of Spinal Modulation, Inc. will further support St. Jude Medical’s mission to help physicians tailor treatment to a patient’s chronic pain condition to achieve superior outcomes. Stimulation of the dorsal root ganglion (DRG) with the Axium system has been shown to provide meaningful relief for pati...
